Viewing Study NCT05025033


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2026-02-22 @ 4:52 PM
Study NCT ID: NCT05025033
Status: COMPLETED
Last Update Posted: 2023-01-18
First Post: 2021-01-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Chemotherapy Combined With Apatinib and PD-1 Antibody
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module